ABM ABM Industries Incorporated - Fundamental Analysis
NEUTRAL
Sign in to save
Save this symbol to a watchlist or track a position.
ABM Stock | Fundamental Analysis & Investment Insights
NYSE
Industrials
Specialty Business Services
Current Price
Live
$45.37
Analyst Target
$54.67
+20.5%
Upside
52W High
$54.9
52W Low
$40.0
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Jan 24, 2026
Market cap
$2.78B
P/E
17.86
ROE
9.1%
Profit margin
1.9%
Debt/Equity
0.95
Dividend yield
2.5%
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
65%
Analysis Accuracy
ABM's deterministic health score is stable with a Piotroski F-Score of 5/9, indicating moderate financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades above its Graham Number of $41.18 at $45.37, suggesting a slight overvaluation on a defensive basis, while forward P/E of 10.43 implies improving earnings expectations. Profitability metrics are modest, with a low ROE of 9.10% and thin margins, though the balance sheet appears manageable with a Debt/Equity of 0.95 and solid liquidity. However, recent earnings misses, bearish insider activity, and weak technical trend counterbalance analyst optimism and a solid dividend yield.
Key Strengths
Stable Piotroski F-Score of 5 indicates core financial stability
Forward P/E of 10.43 suggests earnings improvement expectations
Dividend yield of 2.50% is attractive with a sustainable 40.93% payout ratio
Price/Sales of 0.32 is very low, indicating potential undervaluation relative to revenue
Current and quick ratios (1.49 and 1.35) reflect strong short-term liquidity
Key Risks
Recent earnings performance has been weak: 0 out of last 4 quarters beat estimates
Average earnings surprise over last 4 quarters is -10.85%, signaling declining confidence
Insider selling of $1.37M indicates lack of confidence from management
Technical trend score of 0/100 signals strong bearish momentum
Low profit margin (1.86%) and operating margin (3.45%) limit earnings resilience
AI Fair Value Estimate
Based on comprehensive analysis
$41.18
-9.2% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
60
Strong
75
45
52
60
70
AI Verdict
Neutral with upside risk if earnings stabilize
Key drivers: Low valuation multiples, Recent insider selling, Earnings miss streak, Solid dividend coverage, Improving forward P/E
Confidence
70%
Value
75/100
Ref P/E, PEG, Graham Number
Positives
- P/S of 0.32 is significantly below sector average
- Forward P/E of 10.43 is below current P/E of 17.86
- Graham Number ($41.18) provides conservative floor
Watchpoints
- Current price ($45.37) trades above Graham Number
- No PEG ratio due to uncertain growth visibility
Future
45/100
Ref Growth rates
Positives
- Forward P/E implies earnings recovery
- YoY revenue growth of 5.40% is positive
Watchpoints
- No YoY earnings growth data available
- Recent EPS growth is mixed: Q/Q +7.3% but YoY -2.2%
- Earnings have consistently missed estimates for the last 3 reported quarters
Past
52/100
Ref Historical trends
Positives
- Historically strong earnings surprises pre-2024 (e.g., +70.2%, +108.1%)
- 1Y revenue growth of 5.40% shows resilience
Watchpoints
- Last 4 quarters show declining earnings performance
- 1Y price return of -11.8% underperforms sector
Health
60/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Piotroski F-Score of 5 indicates stable financial condition
- Debt/Equity of 0.95 is manageable
- Current and quick ratios above 1.3 signal liquidity strength
Watchpoints
- No Altman Z-Score available limits distress risk analysis
- Low ROE (9.10%) and ROA (3.89%) suggest inefficient capital use
Dividend
70/100
Ref Yield, Payout
Positives
- Dividend yield of 2.50% is above market average
- Payout ratio of 40.93% is sustainable
- Dividend Strength score of 50/100 indicates moderate reliability
Watchpoints
- No 5-year average yield to assess consistency
- No ex-dividend date provided, limiting transparency
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$45.37
Analyst Target
$54.67
Upside/Downside
+20.5%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for ABM and closest competitors.
Updated 2026-01-23
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
ABM
ABM Industries Incorporated
Primary
|
+26.5% | +7.0% | -11.8% | -3.7% | +8.3% | +0.2% |
|
ATRO
Astronics Corporation
Peer
|
+444.1% | +413.7% | +344.9% | +121.3% | +38.1% | +2.2% |
|
ATS
ATS Corporation
Peer
|
+65.7% | -23.5% | +3.9% | -7.9% | +5.2% | -3.1% |
|
AERO
Grupo Aeromexico, S.A.B. de C.V
Peer
|
+3.6% | +3.6% | +3.6% | +3.6% | -4.9% | +4.2% |
|
ATKR
Atkore Inc.
Peer
|
+58.7% | -38.1% | -15.0% | -8.4% | +10.9% | +0.3% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
17.86
Forward P/E
10.43
PEG Ratio
N/A
P/B Ratio
1.53
P/S Ratio
0.32
EV/Revenue
0.49
EV/EBITDA
10.09
Market Cap
$2.78B
Profitability
Profit margins and return metrics
Profit Margin
1.86%
Operating Margin
3.45%
Gross Margin
13.3%
ROE
9.1%
ROA
3.89%
Growth
Revenue and earnings growth rates
Revenue Growth
+5.4%
Earnings Growth
N/A
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.95
Moderate
Current Ratio
1.49
Good
Quick Ratio
1.35
Good
Cash/Share
$1.73
Quarterly Earnings History
EPS performance vs analyst estimates
2026-03-12
$N/A
2025-12-17
$0.88
-19.0% surprise
2025-09-05
$0.82
-13.6% surprise
2025-06-06
$0.86
-0.0% surprise
Industrials Sector Comparison
Comparing ABM against 122 companies in the Industrials sector
(5 bullish, 61 neutral, 56 bearish)
P/E Ratio
17.86
This Stock
vs
74.17
Sector Avg
-75.9%
(Discount)
Return on Equity (ROE)
9.1%
This Stock
vs
7.57%
Sector Avg
+20.2%
(Excellent)
Profit Margin
1.86%
This Stock
vs
58.43%
Sector Avg
-96.8%
(Weaker)
Debt to Equity
0.95
This Stock
vs
5.2
Sector Avg
-81.8%
(Less Debt)
Revenue Growth
5.4%
This Stock
vs
24.48%
Sector Avg
-77.9%
(Slower)
Current Ratio
1.49
This Stock
vs
2.66
Sector Avg
-44.1%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
ABM
ABM Industries Incorporated
|
NEUTRAL | $2.78B | 17.86 | 9.1% | 1.9% | $45.37 | |
|
ATRO
Astronics Corporation
|
BEARISH | $2.72B | - | -1.7% | -0.4% | $76.34 | |
|
ATS
ATS Corporation
|
NEUTRAL | $2.88B | - | -0.3% | -0.2% | $29.68 | |
|
AERO
Grupo Aeromexico, S.A.B. de C.V
|
BEARISH | $3.08B | 0.48 | -% | 4.9% | $21.09 | |
|
ATKR
Atkore Inc.
|
BEARISH | $2.44B | - | -1.0% | -0.5% | $72.2 |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-13 | JACOBSEN RENE | Chief Operating Officer | Sale | 31,034 | $1,369,319 |
| 2026-01-09 | MAHONEY SEAN MICHAEL | Officer | Stock Award | 17,355 | - |
| 2026-01-09 | VALENTIN RAUL JAVIER | Officer | Stock Award | 18,900 | - |
| 2026-01-09 | RUIZ MELANIE KIRKWOOD | Chief Technology Officer | Stock Award | 8,673 | - |
| 2026-01-09 | TOLAR MIRANDA ROSE | General Counsel | Stock Award | 9,220 | - |
| 2026-01-09 | ORR DAVID MARSHALL | Chief Financial Officer | Stock Award | 13,065 | - |
| 2026-01-09 | SALMIRS SCOTT B | Chief Executive Officer | Stock Award | 123,440 | - |
| 2026-01-09 | JACOBSEN RENE | Chief Operating Officer | Stock Award | 45,117 | - |
| 2026-01-09 | CHIN DEAN A | Officer | Stock Award | 8,148 | - |
| 2026-01-06 | COLLERAN DONALD F | Director | Stock Award | 3,996 | - |
| 2026-01-06 | CLEMENTS CAROL ANN | Director | Stock Award | 3,996 | - |
| 2026-01-06 | WEBB WINIFRED MARKUS | Director | Stock Award | 3,996 | - |
| 2026-01-06 | ALLEN QUINCY L. | Director | Stock Award | 3,996 | - |
| 2026-01-06 | BAKER LEIGHANNE G | Director | Stock Award | 3,996 | - |
| 2026-01-06 | DEVRIES JAMES DAVID | Director | Stock Award | 3,996 | - |
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
BUY
6 analysts
Truist Securities
2026-01-21
Buy
Hold
UBS
2025-12-18
Buy
Neutral
Freedom Capital Markets
2025-12-10
Buy
UBS
2025-09-08
Buy
Buy
Baird
2025-09-08
Outperform
Neutral
Past News Coverage
Recent headlines mentioning ABM from our newsroom.
Newest → oldest
No matching news yet.